Absence of effects of short-term estrogen replacement therapy on resting and exertional QT and QTc dispersion in postmenopausal women with coronary artery disease

PACE - Pacing and Clinical Electrophysiology

Volumn 21, Issue 11 II, 1998, Pages 2392-2395

  Sbarouni, Eftihia ^a   Zarvalis, Elias ^a   Kyriakides, Zenon S ^a   Kremastinos, Dimitrios Th ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

Estrogen; Exercise; QT dispersion

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; CLINICAL ARTICLE; CONFERENCE PAPER; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAM; ESTRADIOL BLOOD LEVEL; ESTROGEN THERAPY; EXERCISE TEST; FEMALE; HUMAN; POSTMENOPAUSE; QT INTERVAL; SEX DIFFERENCE; TORSADE DES POINTES;

AGED; CORONARY DISEASE; CROSS-OVER STUDIES; ELECTROCARDIOGRAPHY; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); EXERCISE TEST; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; TIME FACTORS;

EID: 0031723607     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1998.tb01188.x     Document Type: Article

References (16)

1. Bazett HC. An analysis of the time relationship of electrocardiograms. Heart 1918; 7:353-370.
2. Rautaharju PM, Zhou SH, Wong S, et al. Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol 1992; 8:690-695.
3. Makkar RR, Fromm BS, Steinman RT, et al. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA 1993; 270:2590-2597.
4. Drici MD, Burklow TR, Haridasse V, et al. Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart. Circulation 1996; 94:1471-1474.
5. Larsen JA, Tung RH, Sadananda R, et al. Effect of hormone replacement therapy on QT interval. J Am Coll Cardiol 1998; 31(Suppl. A):264A.
6. Sbarouni E, Kyriakides Z, Nikolaou N, et al. Estrogen replacement therapy and exercise performance in postmenopausal women with coronary artery disease. Am J Cardiol 1997; 79:87-89.
7. Grodstein F, Stampfer MJ. The epidemiology of coronary heart disease and estrogen replacement therapy in postmenopausal women. Prog Cardiovasc Dis 1995; 38:199-210.
8. Grodstein F, Stampfer MJ, Colditz GA, et al. Postmenopausal hormone therapy and mortality. New Engl J Med 1997; 336:1769-1775.
9. Sullivan JM, Zwaag RV, Hughes JP, et al. Estrogen replacement therapy and coronary artery disease-effect on survival in postmenopausal women. Arch Intern Med 1990; 150:2557-2562.
10. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA 1991; 265:1861-1867.
11. Higham PD, Furniss SS, Camphell RW. QT dispersion and components of the QT interval in ischemia and infarction. Br Heart J 1995; 73:32-36.
12. Surawicz B. Will QT dispersion play a role in clinical decision making? J Cardiovasc Electrophysiol 1996; 7:777-784.
13. Sarrel PM. Ovarian hormones and the circulation. Maturitas 1990; 12:287-298.
14. Schenkert H, Danser J, Hense HW, et al. Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation 1997; 95:39-45.
15. Rosano GMC, Leonardo F, Sarrel PM, et al. Cyclic variation in paroxysmal supraventricular tachycardia in women. Lancet 1996; 347:786-788.
16. Kautzner J, Malik M. QT interval dispersion and its clinical utility. PACE; 20 (Pt II):2625-2640.